Loading…
Blood Pressure Control in Patients with Diabetic Kidney Disease
Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease. Blood pressure (BP) control can reduce the risks of cardiovascular (CV) morbidity, mortality, and kidney disease progression. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines have suggested...
Saved in:
Published in: | Electrolyte & blood pressure : E & BP 2022, Vol.20 (2), p.39 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , |
Format: | Article |
Language: | Korean |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Diabetic kidney disease (DKD) is the most common cause of end-stage kidney disease. Blood pressure (BP) control can reduce the risks of cardiovascular (CV) morbidity, mortality, and kidney disease progression. Recently, the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines have suggested the implementation of a more intensive BP control with a target systolic BP (SBP) of |
---|---|
ISSN: | 1738-5997 2092-9935 |